ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Evacetrapib Elicits Antitumor Effects on Colorectal Cancer by Inhibiting the Wnt/β-Catenin Signaling Pathway and Activating the JNK Signaling Pathway

Hu, Limei; Dong, Haiyan; He, Lingyuan; Shi, Mengchen; Xiang, Nanlin; Su, Yixi; Wang, Chen; Tian, Yu; Hu, Yijia; Wang, Huihui; Liu, Huanliang; Wen, Chuangyu*; Yang, Xiangling*南方医科大学; 中山大学; 6
Biological and Pharmaceutical Bulletin2022-9
1被引8阅读
引用收藏
分享

摘要

Despite advances in colorectal cancer (CRC) treatment, most advanced CRC patients who experience disease progression after chemotherapy, targeted therapy, and immunotherapy face a situation in which there is no available medicine. Thus, new therapeutic drugs for CRC are urgently needed. Studies have shown that cholesteryl ester transfer protein (CETP) has a vital role in tumor development and is a possible target for CRC therapy. We found that Evacetrapib, a CETP inhibitor, suppressed CRC cell growth by inhibiting the Wnt/beta-catenin signaling pathway and activating the c-Jun NH2-terminal kinase (JNK) signaling pathway in CRC. Therefore, Evacetrapib displays an anti-cancer effect and is a possible option for treating CRC.

学科与关键词

关键词
Evacetrapibcolorectal cancerWntbeta-cateninc-Jun NH2-terminal kinasecholesteryl ester transfer protein
相关
加载中…
  • Celastrol Inhibits the Proliferation and Induces Apoptosis of Colorectal Cancer Cells via Downregulating NF-κB/COX-2 Signaling Pathways
    Zhang, Hua; Zhao, Xiaojin; Shang, Fajun; Sun, Huan; Zheng, Xu; Zhu, Jiabin*Anti-Cancer Agents in Medicinal Chemistry, 2022, 22(10): 1921-1932.被引 4
  • Cabazitaxel suppresses colorectal cancer cell growth via enhancing the p53 antitumor pathway
    Zhang, Wen; Sun, Ruiqian; Zhang, Yongjun; Hu, Rong; Li, Qian; Wu, Weili; Cao, Xinyu; Zhou, Jiajian; Pei, Jianfeng*; Yuan, Ping*FEBS Open Bio, 2021, 11(11): 3032-3050.被引 2
  • Cannabidiol inhibits invasion and metastasis in colorectal cancer cells by reversing epithelial-mesenchymal transition through the Wnt/β-catenin signaling pathway
    Feng, PanFeng; Zhu, LongXun; Jie, Jing; Yang, PengXiang; Sheng, Nan; Chen, XiangFan*; Chen, XiaJournal of Cancer Research and Clinical Oncology, 2023, 149(7): 3587-3598.被引 8
查看全部 →

发表信息

论文状态
公开发表
期刊
Biological and Pharmaceutical Bulletin
发表日期
2022-09
卷期
第 45 卷, 第 9 期
页码
1238-1245
语言
ENGLISH
成果收录
SCIE
资助标注
Project to Attract High Level Foreign Experts [G20200019016]; China Postdoctoral Scientific Foundation [2020M683114]; Dongguan Science and Technology of Social Development Program [202050715001215]; Project of Administration of Traditional Chinese Medicine of Guangdong Province of China [20211405]

作者

  • H

    Hu, Limei (第一作者)

    6 · sun yat sen univ

  • D

    Dong, Haiyan

    6 · sun yat sen univ

查看全部 13 位作者收起作者
  • H

    He, Lingyuan

    6 · sun yat sen univ

  • S

    Shi, Mengchen

    6 · sun yat sen univ

  • X

    Xiang, Nanlin

    6 · sun yat sen univ

  • S

    Su, Yixi

    6 · sun yat sen univ

  • W

    Wang, Chen

    6 · sun yat sen univ

  • T

    Tian, Yu

    6 · sun yat sen univ

  • H

    Hu, Yijia

    6 · sun yat sen univ

  • W

    Wang, Huihui

    6 · sun yat sen univ

  • L

    Liu, Huanliang

    6 · sun yat sen univ

  • W

    Wen, Chuangyu (通讯)

    6 · sun yat sen univ · southern med univ

  • Y

    Yang, Xiangling (通讯)

    6 · sun yat sen univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417